Momenta Pharmaceuticals Company Profile (NASDAQ:MNTA)

Analyst Ratings

Consensus Ratings for Momenta Pharmaceuticals (NASDAQ:MNTA) (?)
Ratings Breakdown: 4 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $18.78 (60.36% upside)

Analysts' Ratings History for Momenta Pharmaceuticals (NASDAQ:MNTA)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016Goldman Sachs Group Inc.Initiated CoverageNeutral$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Brean CapitalReiterated RatingBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Leerink SwannReiterated RatingOutperform$21.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2016Cowen and CompanyLower Price Target$20.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Stifel NicolausLower Price TargetBuy$29.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016Maxim GroupReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/23/2015Barclays PLCInitiated CoverageEqual Weight$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Sanford C. BernsteinReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Momenta Pharmaceuticals (NASDAQ:MNTA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/3/2016Q116($0.32)($0.35)$28.12 million$19.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2016Q415($0.04)($0.43)$30.42 million$22.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.19)($0.44)$31.76 million$13.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.39)($0.04)$23.59 million$44.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2015Q115($0.48)($0.40)$11.70 million$8.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2015Q414($0.26)($0.31)$23.80 million$21.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314($0.43)($0.56)$13.00 million$9.34 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q214($0.46)($0.51)$11.22 million$11.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q1($0.55)($0.53)$8.41 million$10.79 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2014Q4($0.45)($0.59)$8.50 million$12.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313($0.48)($0.50)$8.60 million$10.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013($0.45)($0.57)$8.85 million$4.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013($0.44)($0.48)$10.28 million$7.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2013Q4 2012($0.41)($0.35)$10.41 million$12.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.27)($0.51)$16.48 million$5.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012($0.17)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012$0.02($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2012$0.13($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2011$1.28$1.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011$1.21$1.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011$0.95$1.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011$0.81$0.77ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Momenta Pharmaceuticals (NASDAQ:MNTA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.36)($0.36)($0.36)
Q3 20161($0.34)($0.34)($0.34)
Q4 20161($0.29)($0.29)($0.29)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Momenta Pharmaceuticals (NASDAQ:MNTA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Momenta Pharmaceuticals (NASDAQ:MNTA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/20/2016Bruce LeicherSVPSell1,000$10.40$10,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Craig A WheelerPresidentSell5,880$10.18$59,858.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Ganesh Venkataraman KaundinyaVPSell1,050$10.18$10,689.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Richard P SheaCFOSell973$10.18$9,905.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016John E BishopVPSell784$10.20$7,996.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/19/2016John E BishopVPSell2,843$9.57$27,207.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016John E BishopVPSell329$9.70$3,191.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016Bruce LeicherSVPSell227$9.65$2,190.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016Craig A WheelerPresidentSell1,688$9.95$16,795.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/22/2016John E BishopVPSell2,848$9.66$27,511.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016Bruce LeicherSVPSell2,000$9.64$19,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016Craig A WheelerPresidentSell9,844$9.37$92,238.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016John E. BishopVPSell357$10.28$3,669.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016Richard P SheaCFOSell1,823$9.64$17,573.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2016Bruce LeicherSVPSell337$10.49$3,535.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2016James M RoachVPSell272$10.49$2,853.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2016Richard P SheaCFOSell183$10.49$1,919.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Craig A WheelerPresidentSell1,688$11.30$19,074.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Michael FrankenInsiderSell520$15.84$8,236.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Craig A WheelerPresidentSell1,766$17.86$31,540.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2015Craig A WheelerPresidentSell2,061$18.05$37,201.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Craig A WheelerPresidentSell1,766$17.70$31,258.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2015Craig A. WheelerPresidentSell51,667$18.00$930,006.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015Craig A WheelerPresidentSell1,766$22.28$39,346.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2015Craig A WheelerPresidentSell2,061$22.02$45,383.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2015James M. RoachVPSell7,011$22.09$154,872.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015James M RoachVPSell6,812$21.80$148,501.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Craig A WheelerPresidentSell1,766$21.77$38,445.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Elizabeth StonerDirectorSell4,570$22.35$102,139.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015John E BishopVPSell21,274$25.50$542,487.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Bruce LeicherSVPSell20,000$23.00$460,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Craig A WheelerPresidentSell155,000$24.20$3,751,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015John E BishopVPSell36,313$23.58$856,260.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Craig A WheelerPresidentSell103,333$22.00$2,273,326.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Bruce LeicherSVPSell40,000$21.00$840,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015James M RoachVPSell25,000$21.70$542,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Craig A WheelerPresidentSell1,766$19.68$34,754.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2015Craig A WheelerPresidentSell2,061$19.67$40,539.87View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015Craig A WheelerPresidentSell51,667$20.00$1,033,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015Ganesh Venkataraman KaundinyaVPSell34,000$19.95$678,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Craig A WheelerPresidentSell6,269$18.75$117,543.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2015Bruce LeicherSVPSell52,910$19.52$1,032,803.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2015James M RoachVPSell50,000$18.70$935,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Richard P SheaCFOSell23,093$15.10$348,704.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2015Richard P SheaCFOSell23,364$14.90$348,123.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Craig A WheelerPresidentSell2,110$13.52$28,527.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Bruce LeicherSVPSell1,891$12.97$24,526.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Craig A WheelerPresidentSell9,563$13.49$129,004.87View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015John E BishopVPSell1,768$12.97$22,930.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Richard P SheaCFOSell1,812$12.97$23,501.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Craig A WheelerPresidentSell1,688$11.91$20,104.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Bennett M ShapiroDirectorSell5,800$12.19$70,702.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014Michael FrankenInsiderSell2,047$12.29$25,157.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Bennett M ShapiroDirectorSell9,903$12.00$118,836.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Bennett M ShapiroDirectorSell1,897$12.00$22,764.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Craig A WheelerPresidentSell2,210$11.59$25,613.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014Craig A WheelerPresidentSell1,768$11.10$19,624.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Craig A WheelerPresidentSell1,768$10.58$18,705.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Bennett M ShapiroDirectorSell3,723$12.00$44,676.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Peter Barton HuttDirectorSell3,640$11.42$41,568.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Craig A WheelerPresidentSell2,209$11.45$25,293.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2014Craig A WheelerPresidentSell1,768$11.54$20,402.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Bennett M ShapiroDirectorSell3,722$12.00$44,664.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Craig A WheelerPresidentSell1,768$11.75$20,774.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Bennett M ShapiroDirectorSell3,721$12.00$44,652.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014Craig A WheelerPresidentSell2,110$12.06$25,446.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2014Craig WheelerPresidentSell1,688$12.08$20,391.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Craig WheelerPresidentSell1,687$11.09$18,708.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Craig WheelerPresidentSell2,109$17.47$36,844.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014John BishopVPSell1,038$17.67$18,341.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014Craig WheelerPresidentSell3,797$17.90$67,966.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Ganesh Venkataraman KaundinyaVPSell33,000$17.96$592,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014John BishopVPSell27,159$19.50$529,600.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2013Bruce LeicherSVPSell13,492$18.00$242,856.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2013Craig WheelerPresidentSell2,215$17.77$39,360.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2013Ganesh Venkataraman KaundinyaVPSell33,211$18.02$598,462.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2013Craig WheelerPresidentSell2,215$17.17$38,031.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Craig WheelerPresidentSell1,772$16.88$29,911.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/11/2013John BishopVPSell5,247$15.46$81,118.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2013Craig WheelerPresidentSell2,109$14.90$31,424.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013Craig WheelerPresidentSell2,109$14.47$30,517.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Craig WheelerPresidentSell1,688$15.43$26,045.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013Richard P SheaCFOSell30,000$16.61$498,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2013Richard P SheaCFOSell10,522$14.61$153,726.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Richard P SheaCFOSell21,550$14.61$314,845.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2013Craig A WheelerPresidentSell2,109$13.03$27,480.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Craig A WheelerPresidentSell2,109$12.83$27,058.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Craig A WheelerPresidentSell1,687$13.33$22,487.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2013Elizabeth StonerDirectorSell2,040$14.00$28,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/15/2013Bruce LeicherSVPSell1,040$12.26$12,750.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Momenta Pharmaceuticals (NASDAQ:MNTA)
DateHeadline
07/27/16 05:34 PMExpected For Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Sales Of $305.705 - Investor Newswire
07/26/16 05:33 PMCan Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Keep Up with Analyst Expectations? - Investor Newswire
07/23/16 09:07 AMShares Stumbling of Late: Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) - TGP
07/23/16 09:07 AMEquity Roundup: Stock Performance Focus on Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) - Press Telegraph
07/22/16 05:05 PMMomenta Pharmaceuticals, Inc. (NASDAQ:MNTA): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 05:05 PMDoes Momenta Pharmaceuticals, Inc. Have Any Gas After Today's Huge Increase? - Consumer Eagle
07/22/16 05:05 PMMomenta Pharmaceuticals Incorporated (NASDAQ:MNTA) Shorts Decreased by 11.11% After Short Covering - Consumer Eagle
07/22/16 05:05 PMWhat's Ahead for Momenta Pharmaceuticals, Inc. After Today's Huge Decline? - Press Telegraph
07/21/16 07:00 AMMomenta Pharmaceuticals Announces Date for Second Quarter 2016 Financial Results Conference Call and Webcast - [GlobeNewswire] - CAMBRIDGE, Mass., July 21, 2016-- Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the ...
07/18/16 10:31 AMStock in Positive Territory for the Quarter: Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) - Engelwood Daily
07/18/16 10:31 AMHow Many Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)'s Analysts Are Bearish? - Consumer Eagle
07/15/16 09:39 AMMomenta Pharmaceuticals Incorporated (NASDAQ:MNTA) Short Interest Increased By 0.79% - Consumer Eagle
07/12/16 09:36 AMStock Performance Rundown on: Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) - Press Telegraph
07/10/16 04:42 PMNext Weeks Broker Price Targets For Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) - Fiscal Standard
07/07/16 05:16 PMCan Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Improve on the Earnings Front? - Engelwood Daily
07/07/16 05:16 PMBroker Outlook For Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) - Fiscal Standard
07/04/16 04:39 PMMomenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Broker Price Targets For The Coming Week - Fiscal Standard
07/02/16 08:02 AMMomenta Pharmaceuticals Incorporated (NASDAQ:MNTA) Sellers Increased By 0.79% Their Shorts - Engelwood Daily
07/01/16 05:15 PM10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate?
07/01/16 08:03 AMNew Broker Ratings For Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) - FTSE News
07/01/16 08:03 AMMomenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Current Analyst Ratings - Fiscal Standard
06/30/16 05:35 PMMomenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Yearly Sales Target At $305.705 - Investor Newswire
06/30/16 08:06 AMHealthcare Sector Equities Under Review - Nanosphere, SciClone Pharma, ConforMIS, and Momenta Pharma
06/28/16 10:04 AMCovering the Bases on Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA): Where is the Stock Going? - Press Telegraph
06/27/16 07:44 AMMomenta Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : MNTA-US : June 27, 2016 -
06/23/16 05:42 PMMomenta Pharmaceuticals Inc. (NASDAQ:MNTA) Stock Momentum at Critical Inflection Point - CML News
06/23/16 07:19 AMMomenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors - [at noodls] - 259678e6-528e-446b-92a4-2ab375135763.pdf June 23, 2016 CAMBRIDGE, Mass., June 23, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization ...
06/23/16 07:17 AMMOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers -
06/22/16 03:17 PMMOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a -
06/21/16 09:40 AMEarnings Recap: Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) - iStreetWire
06/20/16 05:15 AMMomenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Analyst Price Targets For The Coming Week - Fiscal Standard
06/20/16 04:00 AMVisium Insider-Trading Scheme Brought Down by Tip on Mismarking -
06/17/16 05:03 PMWhich way Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) earnings may go - iStreetWire
06/16/16 05:23 PMVisium's Sanjay Valvani charged with insider trading
06/16/16 12:45 PMVisium Hedge Fund Partner Charged in Insider Trading Case -
06/16/16 09:30 AMEarnings Surprise in Focus: Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) - Investor Newswire
06/15/16 11:48 PMUPDATE 3-Visium's Valvani charged with insider trading on FDA leaks - [Reuters] - A Manhattan hedge fund manager was charged on Wednesday with trading on confidential tips about drug approvals, in one of the biggest insider trading cases since a 2014 court ruling made it harder for U.S. prosecutors to pursue them. U.S. Attorney Preet Bharara in Manhattan accused Sanjay Valvani of Visium Asset Management LP of fraudulently making $25 million by gaining advance word about U.S. Food and Drug Administration approvals of generic drug applications.
06/15/16 05:11 PMU.S. rekindles insider trading push, charges hedge fund's Valvani
06/10/16 08:08 AMMomenta Phama (MNTA) Commences M281 Phase 1
06/09/16 07:29 AMMomenta Pharmaceuticals Initiates Phase 1 Trial of M281, an Anti-FcRn Monoclonal Antibody - [at noodls] - a8fb3d19-f663-44ba-aa5c-d1fb8d196afc.pdf June 9, 2016 CAMBRIDGE, Mass., June 09, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization ...
06/08/16 05:38 PMMomenta Phama (MNTA) Plans Presentation of Humira Biosimilar at EULAR 2016
06/08/16 07:18 AMMomenta Pharmaceuticals Announces Data Presentation on M923, a Proposed HUMIRA® (adalimumab) Biosimilar, at EULAR 2016 - [at noodls] - 0136aa7b-5428-4e83-922d-666685e158d4.pdf June 8, 2016 CAMBRIDGE, Mass., June 08, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization ...
06/06/16 08:55 AMMomenta Pharmaceuticals, Inc. (MNTA) Now Covered by Goldman Sachs - Let Me Know About This
06/06/16 06:15 AMCoverage initiated on Momenta Pharma by Goldman -
06/05/16 07:53 AMJPMorgan Chase & Co. Reiterates “Buy” Rating for Momenta Pharmaceuticals, Inc. (MNTA) - Let Me Know About This
06/04/16 08:28 AMMomenta Pharmaceuticals Announces Presentation of Final Data from Phase 1 Trial of Necuparanib in Patients with Pancreatic Cancer at ASCO - [at noodls] - 708972dd-ffdc-4cd5-99cf-36ec559d674e.pdf June 4, 2016 Novel oncology candidate necuparanib had favorable tolerability and encouraging signals of activity in Phase 1 study CAMBRIDGE, Mass., June 04, 2016 ...
06/03/16 08:01 AMStock Review and Earnings Check on Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) - HNN - Stock Review and Earnings Check on Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Momenta Pharmaceuticals, Inc.and more »
06/02/16 05:35 PMBrokerages Expect Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Will Announce Earnings of -$0.29 Per Share - Let Me Know About This - Brokerages Expect Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Will Announce Earnings of -$0.29 Per ShareLet Me Know About ThisMomenta Pharmaceuticals logo Wall Street analysts expect that Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) will announce earnings of ($0.29) per share for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued ...Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) topped earnings-per-share estimates 33% of the timeZergwatchMomenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Analyst ReviewRisers & FallersMomenta Pharmaceuticals, Inc. (NASDAQ:MNTA): Price Target ProjectionsNews TribuneThe Post -Stock Tick Tockall 9 news articles »
06/02/16 08:07 AMBiotech Stocks Update: Express Scripts Holding Company (NASDAQ:ESRX) , Momenta Pharmaceuticals, Inc ... - Is stories - Biotech Stocks Update: Express Scripts Holding Company (NASDAQ:ESRX) , Momenta Pharmaceuticals, Inc ...Is storiesIn most recently trading session on 6/1/2016, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) climbed +1.78% while traded on 1.64 million shares versus it's an average volume of 567.95 thousand shares. The company recorded the last trade with the price ...and more »
06/02/16 08:07 AMAnalyst Earnings Report: Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), PACCAR Inc. (NASDAQ:PCAR) - Beacon Chronicle - Beacon ChronicleAnalyst Earnings Report: Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), PACCAR Inc. (NASDAQ:PCAR)Beacon ChronicleLast Trade: The Company closed its last session at $11.99 with the gain of 1.78%. The market capitalization of the company is $831.99 Million, with the average Volume of 559.11K. The stock currently has its 52-Week High range of $25.56 and 52-week low ...and more »

Social

About Momenta Pharmaceuticals

Momenta Pharmaceuticals logoMomenta Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. It focuses on three product areas: Complex Generics, Biosimilars and Novel Therapeutics. It has developed generic version of Lovenox (enoxaparin sodium injection). Its GLATOPA is a generic version of once-daily COPAXONE 20 milligrams/milliliter (mg/mL) indicated for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS), a chronic disease of the central nervous system characterized by inflammation and neurodegeneration. It is developing M923, which is a biosimilar of HUMIRA and M834 as a biosimilar of ORENCIA. Its oncology product candidate Necuparanib, is an oncology product candidate, which have a range of effects on tumor cells and the environment, in which tumor cells grow. It focuses on M281, which is an Anti-FcRn program.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: MNTA
  • CUSIP: 60877T10
Key Metrics:
  • Previous Close: $11.71
  • 50 Day Moving Average: $11.15
  • 200 Day Moving Average: $10.52
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $800.41M
  • Beta: 1.92
  • Current Year EPS Consensus Estimate: $-1.17 EPS
  • Next Year EPS Consensus Estimate: $-0.76 EPS
Additional Links:
Momenta Pharmaceuticals (NASDAQ:MNTA) Chart for Thursday, July, 28, 2016